Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d43c57226c1bdbd1fd554bd5250692b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_975675100652534e886a1f18a7421098 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db8d5fc2d9fdffc3e8ebe812bfd50f41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fc588a78a7fdd13a6607c99d7d91efe |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-1045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-285 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-285 |
filingDate |
2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9815da179d08076574edd928e368c8aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf68603a9f9a28b09576ab0d28608f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47833d2a4efc44e75ce0b3553f447d77 |
publicationDate |
2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10149900-B2 |
titleOfInvention |
Immunogenic compositions and vaccines derived from bacterial surface receptor proteins |
abstract |
The disclosure provides immunogenic compositions comprising a polypeptide comprising a C-lobe domain or an N-lobe domain of a HIBP surface receptor protein obtainable from or obtained from a Gram-negative bacterial species. The HIBP surface receptor proteins have been modified in such a manner that they are unable to bind host iron binding protein. Methods of making and using these immunogenic positions to prepare animal and human vaccines are also provided. |
priorityDate |
2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |